International Biotechnology Trust PLC Puma Biotechnology, Inc. Transaction History

International Biotechnology Trust PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $2.9 Million - $6.74 Million	-144,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $4.92 Million - $7.14 Million	119,300 Added 477.2%	144,300 $5.07 Million
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $877,560 - $1.27 Million	-21,300 Reduced 46.0%	25,000 $3.48 Million
Q2 2018 Aug 13, 2018	BUY	$48.3 - $68.25 $594,090 - $839,475	12,300 Added 36.18%	46,300 $2.73 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $1.31 Million - $2.18 Million	22,000 Added 183.33%	34,000 $2.31 Million
Q4 2017 Mar 02, 2018	BUY	$93.85 - $132.45 $1.13 Million - $1.59 Million	12,000	12,000 $1.19 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.